Cabot Corp. (CBT) Misses Q4 EPS by 1c, Misses on Revenue; Offers FY25 EPS Guidance
Get Alerts CBT Hot Sheet
Price: $81.48 +0.36%
EPS Growth %: -10.0%
Financial Fact:
Gross profit: 169M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -10.0%
Financial Fact:
Gross profit: 169M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cabot Corp. (NYSE: CBT) reported Q4 EPS of $1.80, $0.01 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $1 billion versus the consensus estimate of $1.01 billion.
GUIDANCE:
Cabot Corp. sees FY2025 EPS of $7.40-$7.80, versus the consensus of $7.06.
For earnings history and earnings-related data on Cabot Corp. (CBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share